265. Lipodystrophy Clinical trials / Disease details
Clinical trials : 112 / Drugs : 155 - (DrugBank : 55) / Drug target genes : 25 - Drug target pathways : 97
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00457639 (ClinicalTrials.gov) | April 2006 | 4/4/2007 | Cholic Acid for Hepatic Steatosis in Lipodystrophy | Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients | Hepatic Steatosis | Drug: Cholic Acid | University of Texas Southwestern Medical Center | FDA Office of Orphan Products Development | Completed | 6 Years | 70 Years | All | 18 | Phase 2 | United States |